Supporting progress & translation of gene & cell therapies
The aim of the British Society for Gene and Cell Therapy is to support scientific progress and promote ethical and efficient translation of gene- and cell-based technologies from the laboratory into the clinic.
The British Society for Gene and Cell Therapy (BSGCT) serves as a collaborative platform to advance Gene and Cell Therapy (GCT) in the UK.
We proactively foster cooperation among stakeholders, including the public, patients, scientists, companies, government, and media to support the optimal development of GCT technologies and therapies.
Our charity is managed by volunteer members via an Elected-Board and Sub-Committees. We rely on the crucial support of our sponsors and members and invite you to get involved.
BSGCT News and Opportunities
Researcher Spotlight: Gabriele Gelezauskaite
Biography: I am a final year iCASE BBSRC AstraZeneca-funded PhD student at the University of Sheffield in Professor Barbaric’s lab,…
Submit your ECR Application – Deadline: Thursday 1st May 2025 at 4.00pm
BSGCT is looking to recruit an early career representative(s) (ECR) to the BSGCT board. This person will be responsible for…
Join the BSGCT Board – Deadline: Thursday 1st May 2025 at 4:00pm.
Nominations are invited from BSGCT members for election to the Board of the BSGCT, to be filled by an online…